Transamerica Financial Advisors Inc. Sells 3,994 Shares of Colgate-Palmolive (NYSE:CL)

Transamerica Financial Advisors Inc. reduced its holdings in Colgate-Palmolive (NYSE:CL) by 38.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,335 shares of the company’s stock after selling 3,994 shares during the period. Transamerica Financial Advisors Inc.’s holdings in Colgate-Palmolive were worth $658,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. purchased a new position in shares of Colgate-Palmolive during the 2nd quarter worth about $25,000. Continuum Advisory LLC boosted its stake in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the period. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $53,000. Finally, Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $64,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Price Performance

NYSE CL opened at $96.59 on Wednesday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock’s fifty day moving average price is $97.74 and its 200 day moving average price is $98.59. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The company has a market cap of $78.91 billion, a price-to-earnings ratio of 27.68, a PEG ratio of 3.40 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on CL shares. Redburn Atlantic raised shares of Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. boosted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. Finally, UBS Group boosted their price objective on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.